Inspirna
New York, US · 5 known investors
Inspirna is a clinical-stage biopharmaceutical company developing first-in-class cancer therapeutics, including oral small molecules and biologics that target newly discovered drivers of metastasis in common cancers such as colorectal, non-small cell lung, and endometrial cancer. It uses its proprietary RNA-DRIVEr platform and microRNA mapping to identify cancer drivers for patients with high unmet medical needs.
BiotechHealthtech
Investors · 5
In the news
Frequently asked questions
- What does Inspirna do?
- Inspirna is a clinical-stage biopharmaceutical company developing first-in-class cancer therapeutics, including oral small molecules and biologics that target newly discovered drivers of metastasis in common cancers such as colorectal, non-small cell lung, and endometrial cancer. It uses its proprietary RNA-DRIVEr platform and microRNA mapping to identify cancer drivers for patients with high unmet medical needs.
- Who are Inspirna's investors?
- Inspirna's investors include Sofinnova Partners, Start Capital, Vivo Capital, Novo Holdings, Sands Capital Ventures.
- Where is Inspirna headquartered?
- Inspirna is headquartered in New York, US.